Back to Search Start Over

First estimates of diffuse gastric cancer risks for carriers of CTNNA1germline pathogenic variants

Authors :
Coudert, Marie
Drouet, Youenn
Delhomelle, Hélène
Svrcek, Magali
Benusiglio, Patrick R
Coulet, Florence
Clark, Dana Farengo
Katona, Bryson W
van Hest, Liselotte P
van der Kolk, Lizet E
Cats, Annemieke
van Dieren, Jolanda M
Nehoray, Bita
Slavin, Thomas
Spier, Isabel
Hu¨neburg, Robert
Lobo, Silvana
Oliveira, Carla
Boussemart, Lise
Masson, Laure
Chiesa, Jean
Schwartz, Mathias
Buecher, Bruno
Golmard, Lisa
Bouvier, Anne-Marie
Bonadona, Valérie
Stoppa-lyonnet, Dominique
Lasset, Christine
Colas, Chrystelle
Source :
Journal of Medical Genetics (JMG); 2022, Vol. 59 Issue: 12 p1189-1195, 7p
Publication Year :
2022

Abstract

BackgroundPathogenic variants (PV) of CTNNA1are found in families fulfilling criteria for hereditary diffuse gastric cancer (HDGC) but no risk estimates were available until now. The aim of this study is to evaluate diffuse gastric cancer (DGC) risks for carriers of germline CTNNA1PV.MethodsData from published CTNNA1 families were updated and new families were identified through international collaborations. The cumulative risk of DGC by age for PV carriers was estimated with the genotype restricted likelihood (GRL) method, taking into account non-genotyped individuals and conditioning on all observed phenotypes and genotypes of the index case to obtain unbiased estimates. A non-parametric (NP) and the Weibull functions were used to model the shape of penetrance function with the GRL. Kaplan-Meier incidence curve and standardised incidence ratios were also computed. A ‘leave-one-out’ strategy was used to evaluate estimate uncertainty.ResultsThirteen families with 46 carriers of PV were included. The cumulative risks of DGC at 80 years for carriers of CTNNA1PV are 49% and 57%, respectively with the Weibull GRL and NP GRL methods. Risk ratios to population incidence reach particularly high values at early ages and decrease with age. At 40 years, they are equal to 65 and 833, respectively with the Weibull GRL and NP GRL.ConclusionThis is the largest series of CTNNA1families that provides the first risk estimates of GC. These data will help to improve management and surveillance for these patients and support inclusion of CTNNA1in germline testing panels.

Details

Language :
English
ISSN :
00222593 and 14686244
Volume :
59
Issue :
12
Database :
Supplemental Index
Journal :
Journal of Medical Genetics (JMG)
Publication Type :
Periodical
Accession number :
ejs61190574
Full Text :
https://doi.org/10.1136/jmg-2022-108740